Princeton, NJ — Antibodies are an essential part of the laboratory toolkit, but their quality and applicability are highly variable. Identifying the best antibody for an experiment is critical for maximizing the chances of getting good results first time round, saving both time and money. But deciding which antibody to use on important samples can […]
Rockville, MD — There is a significant unmet need for accurate and precise biomarker tests for clinical trials, drug development and medical research. V-PLEX simultaneously measures multiple biomarkers using assays that are grouped into panels for optimal and consistent performance. The V-PLEX immunoassay menu focuses on emerging biomarkers that are generally not available on traditional […]
San Francisco — SeaChange Pharmaceuticals Inc., a privately held platform and products pharmaceuticals company, is pleased to announce the immediate availability of SEAware™, its proprietary Similarity Ensemble Approach (SEA) software, that allows analysis and visualization tools for prediction of drug and other small molecule activity and toxicity against biological targets. Three levels of software are […]
Munich, Germany – Genomatix today announced it has added the Genomatix Pathway System (GePS) to BaseSpace Apps, Illumina’s dedicated applications store and informatics community dedicated to advancing genomic analysis. Using GePS, researchers can generate and visualize genetic networks and pathways and easily access a multitude of data on the genes and gene-gene connections they consist […]
Mountain View, CA — Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH). The grant – $5.25 […]
Florence – Real hope in identifying new tools in the fight against cancer. Menarini has completed its acquisition of Silicon Biosystems which has patented DEPArray ™, the first technology of its kind that is able to automatically isolate rare single cancer cells in blood while keeping them intact, alive and capable of reproducing themselves by […]
MEDFORD, MA — Hepregen Corporation, leader in the development of next generation HepatoPac(TM) and HepatoMune(TM) cell-based assay products, announced today the commercial launch of the Company’s first application-oriented Rat HepatoPac(TM) kits designed specifically for use in metabolite identification and profiling. A kit may be ordered that contains either Wistar-Hahn or Sprague-Dawley rat hepatocytes. Much like […]
BILLERICA, Mass.– EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced a $30,000 donation to charity: water in recognition of World Water Week. As a leading supplier of products, services and solutions including water purification to the Life Science industry, access to clean water is an important charitable initiative for […]
Austin, Texas and Auckland, New Zealand — Emergent Technologies, Inc. a leading innovation solutions company and KODE Biotech, Ltd, developer of the revolutionary KODE™ biosurface modification technology, have entered into a commercialization agreement in which Emergent will be KODE Biotech’s agent for technology commercialization. The agreement provides for revenue sharing between Emergent and KODE Biotech […]
Austin, Texas and Auckland, New Zealand – Emergent Technologies, Inc. a leading innovation solutions company and KODE Biotech, Ltd, developer of the revolutionary KODE™ biosurface modification technology, have entered into a commercialization agreement in which Emergent will be KODE Biotech’s agent for technology commercialization. The agreement provides for revenue sharing between Emergent and KODE Biotech […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
